首页 › 基金 › Soleus Capital Management, L.P. › EWTX

Soleus Capital Management, L.P. 对 EWTX 的持仓历史

EDGEWISE THERAPEUTICS INC · 医疗保健

Soleus Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 EWTX(EDGEWISE THERAPEUTICS INC)329,987 股,市值约 US$13.4M,约占其申报组合的 0.48%,在其申报持仓中市值排名第 48 位。 Soleus Capital Management, L.P. 最近 8 个申报季度中有 7 个季度披露了 EWTX 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)329.99K 股
申报持仓市值$13.40M
组合权重0.48%
首次申报Q4 2024
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Soleus Capital Management, L.P. 对 EWTX 的持仓演变

Soleus Capital Management, L.P. 于 Q4 2024 首次披露 EWTX 持仓:183,300 股(约 US$4.9M)。 该持仓在 Q1 2026 达到峰值 1,449,915 股,市值约 US$45.7M。 在 7 次申报中,Soleus Capital Management, L.P. 2 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 329,987 股、市值约 US$13.4M,环比减持 -120,902 股。。 持仓曾出现大幅变动:Q1 2025 减持约 61% (随后一个季度股价下跌 40%)、Q1 2026 增持约 59% (随后一个季度股价上涨 29%)、Q2 2026 减持约 69% (随后一个季度股价基本持平)。

逐季持仓明细

季度股数金额变化
Q4 2024 183.30K $4.89M 新进
Q1 2025 72.30K $1.59M 减持
Q2 2025 76.49K $1.00M 增持
Q4 2025 910.00K $22.58M 新进
Q1 2026 1.45M $45.67M 增持
Q2 2026 450.89K $18.32M 减持
Q3 2026 329.99K $13.40M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 EWTX 与 13F 数据

EWTX(EDGEWISE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 EWTX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 EWTX 的基金

查看 EWTX 的全部基金持有人 →

常见问题

How long has Soleus Capital Management, L.P. held EWTX?

Soleus Capital Management, L.P. has disclosed EWTX holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

What is Soleus Capital Management, L.P.'s current position in EWTX?

As of Q3 2026, Soleus Capital Management, L.P. holds 329.99K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $13.40M, representing 0.48% of its reported portfolio and ranking #48.

Has Soleus Capital Management, L.P. been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. reduced its position in EWTX. The position peaked in Q1 2026 at 1.45M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.